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مراجعة إكلينيكية جلودة الرعاية الصحية ملرضى السكري يف مستشفى 
البحرين العسكري
مروة منري البحارنة، ديفيد ليونارد ويتفورد
امللخ�ص: الهدف: اأثبتت املراجعات االإكلينيكية للرعاية ال�سحية االأولية يف مملكة البحرين اأن الرعاية املقدمة ملر�سى ال�سكري ال ت�ستويف 
البحرين. م�ست�سفيات  اأحد  يف  ال�سكري  ملر�سى  الرعاية  جودة  تقييم  يف  نوعها  من  االأوىل  الدرا�سة  هذه  تعد   . دوليا ً املعتمدة   الطريقة: مراجعة اإكلينيكية ا�ستعادية لعينة ع�سوائية من املر�سى املرتددين على عيادة الغدد ال�سماء و ال�سكري يف م�ست�سفى البحرين  االأهداف 
كرياتينني و الوزن بن�سبة تفوق %90 من املر�سى. يف حني لقت املقايي�س االأخرى كالتدخني )%8( و من�سب كتلة اجل�سم )%19( ن�سبة و�سيط العمر 54 عاما ً. بلغت ن�سبة االإ�سابة بالنوع االأول لل�سكري %5. متت متابعة املعدل الرتاكمي لل�سكر، �سغط الدم، ن�سبة الدهون، املقايي�س االأ�سا�سية ونتائج جودة الرعاية ، ومت حتليل البيانات اإح�سائيا ً. النتائج: %74 من عينة املر�سى ا�ستملت على الذكور و كان الع�سكري خالل 15 �سهرا ًمتتالية حتى يونيو2010. متت مراجعة ال�سجالت الطبية اإلكرتونيا ًو يدويًا ل 287 م�سابا بال�سكري لتقييم 
متابعة اأقل. كما كانت ن�سبة التحري عن م�ساعفات ال�سكري قليلة، حيث مت فح�س �سبكية العني )%42(، فح�س القدم )%22( و اختبار 
اأن تطبيق معايري اجلودة القائم على االأدلًة ال يزال ي�سكل  الدرا�سة  اخلال�صة: بينت هذه  البيل االألبومينية الزهيدة )%23( من املر�سى. 
حتديات للممار�سات احلالية يف رعاية مر�سى ال�سكري ، حيث اأن ن�سبة التحري عن م�ساعفات ال�سكري يف عيادة ال�سكر يف هذا امل�ست�سفى 
منخف�سة. يوؤكد املوؤلفون على اأهمية تطبيق اأ�سلوب منهجي يف رعاية مر�سى ال�سكري يهدف اإىل حت�سني جودة الرعاية املقدمة ملر�سى 
ال�سكر مما يوؤدي اإىل تقليل خطر االإ�سابة باأمرا�س القلب و االأوعية الدموية وبالتايل تقليل تكاليف الرعاية ال�سحية على املدى البعيد.
مفتاح الكلمات: ال�صكري، �صمان اجلودة، الرعاية ال�صحية، مراجعة اإكلينيكية، البحرين.
abstract: Objectives: Primary care audits in Bahrain have consistently revealed a failure to meet recognised 
standards of delivery of process and outcome measures to patients with diabetes. This study aimed to establish for 
the first time the quality of diabetes care in a Bahraini hospital setting. Methods: A retrospective clinical audit was 
conducted of a random sample of patients attending the Diabetes and Endocrine Center at the Bahrain Defence 
Forces Hospital over a 15-month period which ended in June 2010. The medical records of 287 patients with 
diabetes were reviewed electronically and manually for process and outcome measures, and a statistical analysis 
was performed. Results: Of the patients, 47% were male, with a median age of 54 years, and 5% had type 1 diabetes. 
Measured processes, including haemoglobin A1c, blood pressure, lipids, creatinine and weight, were recorded in 
over 90% of the patients. Smoking (8%) and the patient’s body mass index (19%) were less frequently recorded. 
Screening for complications was low, with retinal screening in 42%, foot inspection in 22% and microalbuminuria 
in 23% of patients. Conclusion: This study shows that the implementation of recognised evidence-based practice 
continues to pose challenges in routine clinical care. Screening levels for the complications of diabetes were low 
in this hospital diabetes clinic. It is important to implement a systematic approach to diabetes care to improve the 
quality of care of patients with diabetes which could lead to a lowering of cardiovascular risk and a reduction in 
healthcare costs in the long term.
Keywords: Diabetes; Quality; Care; Audit; Bahrain.
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Advances in Knowledge
- Clinical audits of diabetes care have been conducted at primary care settings in Bahrain and have shown underperformance compared 
to evidence-based practice recommendations.
- This study is the first clinical audit conducted in a secondary care setting in Bahrain and reveals a similar underperformance compared 
with international standards of diabetes care. The reasons for this need to be explored and suggestions for change made.
Application to Patient Care
- This study suggests that a more systematic approach to diabetes care would lead to a lowering of cardiovascular risk and improved 
detection of complications at an earlier stage, leading to an improvement in patient outcomes.
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The rising prevalence of diabetes is placing an enormous economic and health burden on the nations of the world.1 The 
majority of this burden is related to the treatment 
of and mortality from the complications of diabetes. 
There is abundant evidence to indicate that good 
control of glycaemia, blood pressure and lipids 
in patients with diabetes reduces the risk of both 
microvascular and macrovascular complications.2–4 
In addition, early detection of complications from 
diabetes enables early intervention leading to 
improved outcomes.5 There is also good evidence 
that the delivery of structured diabetes care to 
the population, combined with increased patient 
involvement and self-management, improves the 
long-term outcomes of diabetes.6–8 Yet it remains 
a challenge to translate the wealth of research 
evidence into practice, although reports from some 
countries suggest this is being addressed.9,10
Bahrain has the ninth highest prevalence of 
diabetes in the world, with an estimated prevalence 
of 22.4% in 2012.11 Coping with such a high 
prevalence demands the involvement of both 
primary and secondary care. Clinical audits of 
diabetes care within primary care in Bahrain have 
consistently shown an underperformance compared 
with agreed standards.12–14 They also compare less 
than favourably with the clinical audits from some 
other countries.15–18 There have, to date, been no 
published clinical audits of hospital-based diabetes 
care in Bahrain. This study aimed to establish the 
quality of diabetes care in a Bahraini secondary care 
setting.
Methods
The population of Bahrain is approximately one 
million, 40% of whom are expatriates. The national 
health service provides free care at the point-of-
contact for Bahraini citizens. It does not have a 
fully established shared care diabetes service, with 
many patients having direct access to secondary 
care services. The Bahrain Defence Forces (BDF) 
Hospital is the second largest hospital in Bahrain, 
with 400 beds, and serves inpatient, outpatient 
and emergency patients. The main mission of the 
BDF Hospital is to provide healthcare services for 
the military and interior forces and their families, 
emergency services for the public, and specialised 
medical care for referral patients, government 
dignitaries and the royal court. The majority of 
patients have an association with the military or 
interior forces. Care for patients with diabetes is 
delivered in a dedicated Diabetes & Endocrine 
Center with doctors, specialist nurses, dietetic and 
podiatry support. Approximately 3,500 patients 
attend the Diabetes & Endocrine Center at the BDF 
Hospital. Appointment intervals for patients with 
diabetes vary according to the individual need, from 
weekly to 6 monthly, with a median of 4 months.
The study was designed as a retrospective 
clinical audit of the medical records of a random 
sample of all patients attending for diabetes care 
in the Diabetes & Endocrine Center at the BDF 
Hospital within the previous 15-month period to 
June 2010. Permission to carry out the clinical audit 
was given by the BDF Hospital.
A sample size of 353 patients was estimated to 
give a 95% chance of being within 5% of the true 
result of establishing the prevalence of the main 
process measures (haemoglobin A1C test [HbA1c], 
blood pressure and low-density lipoprotein [LDL] 
cholesterol) for this population size (3,500). As 
there is no dedicated diabetes register, a computer-
generated random sample of 500 patients attending 
the BDF Diabetes & Endocrine Center was taken 
from the hospital database, allowing for an estimated 
20% of patients without diabetes (hypothyroidism, 
impaired glucose tolerance or gestational diabetes 
mellitus). Some patients were excluded (n = 213) 
as they did not have diabetes mellitus or were aged 
under 18 years, leaving a sample size of 287 patients. 
This gives a 95% chance of being within 6% of the 
true result for this population.
Data were collected from both the electronic 
and manual hospital records of the patients in the 
sample. Data collection was carried out in July and 
August 2010, and parameters recorded between 1st 
April 2009 and 30th June 2010 were searched for. 
This 15-month duration was chosen to allow for 
delayed appointments since guidelines indicate that 
all parameters, including retinal screening, should 
have been completed at least annually. However, only 
the latest available parameter was included in the 
study in order to avoid data duplication. A selection 
of patient records was reviewed by two researchers 
to ensure reliability. Data were entered directly into 
an Excel spread sheet (Microsoft Inc., Redmond, 
Washington, USA) from the medical records 
by the researcher. Parameters included patients' 
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demographic details; the presence of vascular risk 
factors (hyperglycaemia, hyperlipidaemia and 
hypertension [HTN]) and their levels of control; 
medications, and the screening for and the presence 
of complications. Demographics, laboratory 
investigations and medications were available from 
the electronic records; other data were collected 
from the manual records. Complications were 
deemed to be present if a diagnosis was recorded 
in the medical records. Statistical analysis was 
performed using the Statistical Package for the 
Social Sciences (SPSS), Version 17 (IBM Corp., 
Chicago, Illinois, USA). Descriptive analyses were 
performed, and the variables were cross-tabulated 
using parametric and non-parametric tests of 
association. Significance was defined as a P value of 
less than 0.05.
Results
Manual medical records were missing for 24 of the 
287 patients, resulting in 263 full data-sets. Of the 
287 patients, 136 (47.4%) were male. The median age 
was 54 years (range 18–87 years) and the median 
age at diagnosis was 43 years (range 3–79 years); 14 
(5.4%) patients had type 1 diabetes.
Screening for cardiovascular risk factors and 
complications of diabetes are summarised in Table 
1. A total of 53 (20%) patients were recorded as 
having ischaemic heart disease (IHD), 17 (6.5%) 
had cerebrovascular disease (CVD) and 10 
(3.8%) had peripheral vascular disease. Also, 72 
(27.4%) patients were recorded as having diabetic 
retinopathy, 27 (10.3%) diabetic nephropathy and 
26 (9.9%) diabetic neuropathy. A total of 187 (71%) 
patients were recorded as having HTN and 181 
(69%) had hyperlipidaemia (with raised LDL).
On review of the medications, 182 (69%) 
patients were on metformin, 143 (54%) on 
sulfonylureas, 29 (11%) on other oral hypoglycaemic 
agents, 122 (46%) on combination hypoglycaemic 
medication, and 111 (42%) on insulin. Of these 
111, 14 had type 1 diabetes.  The others had type 
2 diabetes and were also taking oral hypoglycemic 
agents. A total of 138 (52%) patients were on 
antiplatelet agents or anticoagulants, 173 (66%) 
on lipid-lowering agents and 188 (71%) on anti-
hypertensive medications. Patients with established 
macrovascular complications were more likely to be 
on antiplatelet agents (82% versus 42%; χ2 = 32.1, 1 
Table 1: Processes and outcome measures of diabetic patients 
at the Bahrain Defence Forces Hospital
Processes 
measured/recorded 





*Systolic BP, mmHg 260 (98.8)
<130 67 (26)
146 mmHg (± 22.6)
>160 65 (24.7)
*Diastolic BP, mmHg 260 (98.8)
<70 60 (23)












2.8 mmol/L (± 0.9)
>2.6 177 (61.7)
HDL cholesterol 274 (95.5) 1.1 mmol/L (± 0.3)





*Alcohol intake 4 (1.5)
*Height 42 (16)
*Weight 240 (91.2)
*BMI, Kg/m2 50 (19)
<25 7 (14)




*Retinal screening 111 (42)
*Foot inspection 59 (22)
*Podiatrist visits 7 (3)
Albumin:creatinine 
ratio
67 (23.3) 4.5 mg/g (+/-9)
Creatinine 278 (96.8) 77.7 mmol/l (+/-85)
* n = 263 as manual medical records missing for 24 of the total 287 patients.
SD = standard deviation; HbAc1 = haemoglobin Ac1; BP = blood pressure; 
LDL = low-density lipoprotein; HDL = high-density lipoprotein; BMI = body 
mass index.
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degrees of freedom [df ], P <0.001). Men aged over 
50 years (66% versus 27%; χ2 = 17.0, 1 df, P <0.001) 
and women aged over 60 years (77% versus 40%; χ2 
= 17.1, 1 df, P <0.001) were also more likely to be on 
antiplatelet agents.
Women were found to have higher high-density 
lipoprotein (HDL) levels (mean HDL 1.23, 95% 
confidence interval [CI] 1.18–1.28) compared to 
men (mean HDL 1.01, 95% CI 0.98–1.05). Older age 
was associated with a lower HbA1c (F-test = 7.16, 
1 df, P = 0.008), higher blood pressure (F = 9.96, 
1 df, P = 0.002), increased diabetic complications 
(F = 2.34, 56 df, P <0.001) and increased poly-
pharmacy (F = 2.48, 56 df, P <0.001).
The process and outcome measures from this 
study were compared with the standards of care 
achieved in other local and international audits 
[Table 2].14,17,19,20
Discussion
This study reveals that the delivery of recognised 
evidence-based interventions to improve diabetes 
outcomes has not been fully realised in this hospital 
diabetes clinic in Bahrain. In particular, control of 
hyperglycaemia and HTN lags behind that achieved 
in other countries.10,15–20 The impact of failing to 
lower cardiovascular risk in patients with diabetes is 
likely to be considerable, with a higher progression 
to micro- and macrovascular complications, and 
the subsequent increased personal and economic 
costs associated with diabetes complications.1 The 
impact of the failure to achieve adequate control of 
cardiovascular risk factors in patients with diabetes 
can be determined. A 10% reduction in HbA1c 
levels, from the population mean of 8.2% in this 
study to a population mean of 7.2%, would lead 
to a risk reduction of 15% for all adverse diabetes 
outcomes.21 Similarly, a 10 mmHg reduction in the 
mean population systolic blood pressure would 
lead to a 22% reduction in risk of coronary heart 
disease events and a 41% reduction in strokes.22 
Lipid lowering has similar effects. The importance 
of striving for improved control of risk factors for 
the complications of diabetes not only contributes 
to improving the quality of patients᾿ lives but also 
to reducing healthcare costs. Such improvements 
have been documented in the UK,20 the USA10 and 
the United Arab Emirates.17
However, this study has shown that many 
process measures are carried out for the majority 
of patients, and this compares favourably with the 
situation in other countries. It is difficult to explain 
the low levels of recording of lifestyle behaviours 
that significantly contribute to cardiovascular 
risk, such as smoking and alcohol consumption. 
Cultural barriers to asking about these habits may 
Table 2: Comparison of process and outcomes measures in the diabetes 
clinics of the Bahrain Defense Forces Hospital (Bahrain), Isa Town 
Health Centre (Bahrain), Diabetes Centre (Saudi Arabia), Al-Ain 
Health Centres (United Arab Emirates) and Wales (UK). All figures are 

























% % % % %
HbA1c 96.8 65.9 88.1 76 92
BP 98.8 91.8 100 91.9 94.7
Cholesterol 95.8 74.3 NR 80.3 91
Creatinine 96.8 NR NR NR 91
BMI 19 NR 100 83.5 89
Retinal 
screening
42 31.9 35.4 31.3 82
Peripheral 
pulses
13 NR 12.7 NR 83
Neuropathy 
testing
17 NR 12.7 NR 83
Microalbumin 23.3 33.4 28.8 83.6 85
Outcomes
HbA1c, %
<7 32 20.4 8.1 45.6 NR
<7.5 45.7 29.4 NR NR 63
>10 19 34.5 34.6 10 7.9
BP, mmHg
<130/80 22 13.7 36.5 42.9 51.1








<5 68.6 40.2 NR 79.6 78.3
BDF = Bahrain Defense Forces Hospital; HC = health centre; UAE = United Arab Emirates 
HbAc1 = haemoglobin Ac1; BP = blood pressure; NR = not recorded; BMI = body mass 
index; LDL = low-density lipoprotein.
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play a part, although it is difficult to understand 
why doctors should not seek a smoking history 
from every patient when rates of smoking in 
Bahrain are similar to most developed countries. 
Failure to record these habits reduces cost-effective 
opportunities to counsel about smoking and 
alcohol cessation or reduction.23 The absence of 
height-recording in order to establish body mass 
index (BMI) is similarly worrying in a generally 
obese population, as dietary advice to encourage 
weight loss has been shown to improve HbA1c.23,24 
In addition, screening for complications in this 
hospital clinic may be comparable with that in other 
Gulf countries but is much less than that achieved 
in England and Wales.19 The delivery of diabetes 
care to the population in England and Wales has 
demonstrated that screening for complications 
of diabetes in the majority of the population is 
feasible.20 The prevalence of macrovascular events 
in the BDF Endocrinology & Diabetes Center are 
similar to those cited by the Centers for Disease 
Control and Prevention [CDC] (IHD: 20.2% versus 
20% and CVD: 7.9% versus 6.5%, for the CDC in 
2007 versus the BDF in 2010, respectively).
However, the prevalence of retinopathy is higher 
(19.7% versus 27.4%, for the CDC in 2009 versus the 
BDF in 2010, respectively).25 The CDC’s rates of 
HTN and hyperlipidaemia in 2007 are comparable 
to the study population (HTN: 67% versus 71% and 
hyperlipidaemia: 62.6% versus 68.8%).26 However, 
the figures from the BDF Endocrinology & Diabetes 
Center are based on the low rates of screening 
for complications; the reality is that the rates 
of microvascular complications are likely to be 
higher than those recorded in the patients’ medical 
records. In the context of continuing evidence of 
suboptimal care and poor outcomes, the question 
arises as to what accounts for the relative success 
of some systems of diabetes care. Delivering high-
quality care to people with diabetes is challenging. 
A systematic review of interventions to improve 
diabetes care in the community underlined the 
need for multifaceted professional interventions to 
enhance the performance of health professionals 
in managing diabetes; organisational interventions 
that facilitate the recall and structured review of 
patients; patient-oriented interventions to improve 
outcomes associated with patient education 
and behavioural change, and enhancements in 
the role of nurses in the provision of diabetes 
care.23,27 It is increasingly clear from this existing 
evidence that the challenge of providing uniformly 
effective diabetes care has thus far defied a simple 
solution; multifaceted and complex interventions 
are necessary for the success of a diabetes care 
system.6,23,27 Features of successful programmes 
include diabetes self-management education; 
adoption of practice guidelines; use of checklists 
and annual reviews; prompting; clinical audits and 
feedback; quality improvement programmes, and 
electronic medical records that allow prospective 
identification of those needing assessments or 
treatment modifications. These records can also be 
utilised in the waiting room to deliver questionnaires 
on well-being and to access data on the current 
condition of the patient as well as delivering patient 
education on diabetes.28,29 Finally, teamwork that 
incorporates nurses or other healthcare workers in 
the implementation of detailed algorithms of care 
contributes to a successful programme.
Diabetes services that incorporate more of 
these elements demonstrated lower HbA1c levels 
and lower cardiovascular risk scores.28 The absence 
of many of these features in the BDF Hospital 
Endocrinology & Diabetes Center likely contributes 
towards some aspects of the lower quality care 
highlighted in this study, particularly the lack of 
screening for smoking and for the complications of 
diabetes.
The main strength of this study is that it is the 
first published clinical audit of diabetes care within 
a secondary care setting in Bahrain. Second, it 
reflects the current practice at the diabetes clinic, 
thereby highlighting deficiencies and opening doors 
for quality improvement. This is deemed to be an 
important step in improving quality.30 Finally, this 
study will serve as a baseline for future clinical 
audits of the quality of diabetes care.
There are several weaknesses to this study. First, 
the measures audited did not include dietician 
consultations, despite the large population of obese 
diabetics in Bahrain. Secondly, the current practice 
for prescribing or modifying medications for 
defined levels of HbA1c, blood pressure and lipids 
was not examined. Additionally, the population of 
patients enrolled in the study were from the BDF 
Hospital; hence, they had an association with the 
military or interior forces, and thus making it 
difficult to generalise the findings of the study to 
the entire Bahraini population. Moreover, the final 
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size of the study sample was 287, which is less than 
the calculated required sample size of 353 patients. 
Although this indicates that the study is slightly 
underpowered based on the original calculations, 
this is unlikely to lead to any change in the conclusions 
from the study. Finally, as with all audits, this study 
measured restrospective records of data, and as 
such cannot ascertain whether the procedures 
were accurately carried out. This may lead to the 
under-representation of some procedures that were 
performed but were not recorded, or that could not 
be identified due to missing records. It could also 
lead to the over-representation of some procedures, 
for instance when the actual examination was 
cursory but recorded as being complete.
Conclusion
Overall, this study has highlighted several potential 
areas for improving the quality of diabetes care in 
the BDF Hospital Endocrinology & Diabetes Center. 
Of particular importance is the need for improving 
the control of cardiovascular risk factors and 
screening for diabetes complications. This is most 
likely to occur through a systematic approach to 
the delivery of diabetes care, incorporating many of 
the key elements of chronic disease management as 
outlined above. This should lead to improvements 
in the quality of life of patients with diabetes and 
lower healthcare costs in the long-term. There is 
also a need for regular clinical audits at the primary 
and secondary care settings to ensure continuous 
monitoring and improvement of the quality of 
diabetes care in Bahrain. There are plans to repeat 
this study in the future in the hope that many of the 
deficiencies will have been addressed, leading to an 
overall improvement in diabetes care.
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